Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Sees Large Decrease in Short Interest

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the recipient of a significant decline in short interest in December. As of December 31st, there was short interest totalling 500 shares, a decline of 28.6% from the December 15th total of 700 shares. Based on an average trading volume of 7,200 shares, the short-interest ratio is currently 0.1 days.

Relief Therapeutics Stock Performance

RLFTF stock traded up $0.08 during midday trading on Friday, hitting $4.27. 482 shares of the company’s stock were exchanged, compared to its average volume of 4,398. The stock’s fifty day moving average price is $5.04 and its 200-day moving average price is $3.68. Relief Therapeutics has a one year low of $1.10 and a one year high of $7.66.

About Relief Therapeutics

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.